Separation and measurement method of besifloxacin hydrochloride and isomer of besifloxacin hydrochloride

A technology for besifloxacin hydrochloride and enantiomers, applied in the field of analytical chemistry, can solve the problems of complex pretreatment process, failure to find, poor operability, etc., and achieve simple sample pretreatment process, accurate separation and detection , the effect of strong operability

Active Publication Date: 2015-03-25
SUNSHINE LAKE PHARM CO LTD
View PDF2 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] Zhangting WANG et al. screened a large number of chiral chromatographic columns and investigated possible chiral separation techniques in CHIRALITY 24:526–531 (2012), but failed to find a direct separation of besifloxacin hydrochloride and its enantiomer. Constructed method; Chinese patent application CN201110326752.3 adopts deriva

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Separation and measurement method of besifloxacin hydrochloride and isomer of besifloxacin hydrochloride
  • Separation and measurement method of besifloxacin hydrochloride and isomer of besifloxacin hydrochloride
  • Separation and measurement method of besifloxacin hydrochloride and isomer of besifloxacin hydrochloride

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0027] Example 1

[0028] Apparatus and conditions

[0029] American Agilent 1260 high performance liquid chromatography system and workstation; automatic sampling;

[0030]

[0031]

Example Embodiment

[0032] Example 2

[0033] Experimental steps

[0034] The diluent or blank solution is the mobile phase phase A / phase B=55 / 45(V:V);

[0035] Take about 20 mg of besifloxacin hydrochloride raw material (prepared according to the method disclosed in Chinese patent CN 200880003118), accurately weigh it into a 10 mL brown measuring flask, dissolve and dilute to the mark with a diluent, and shake it up as the test solution.

[0036] Take the blank solution and the test solution separately, perform high performance liquid chromatography analysis according to the conditions of Example 1, record the chromatogram, and see the results figure 1 , figure 2 . figure 2 It shows that the separation and detection method of the present invention can separate besifloxacin hydrochloride and its enantiomers, and the high-performance liquid chromatograph shows a resolution of 3.56.

Example Embodiment

[0037] Example 3

[0038] Take about 20 mg of Besifloxacin Hydrochloride API (prepared in accordance with the method of CN 201310479217.0) for the test product, accurately weigh it into a 10 mL brown volumetric flask, dissolve it with a diluent ultrasonically and dilute to the mark, shake it, and use it as the test product solution.

[0039] Take the test solution, perform HPLC analysis according to the conditions of Example 1, record the chromatogram, and see the results image 3 .

[0040] image 3 It is proved that this method can be used for the quality monitoring of besifloxacin hydrochloride, and the high performance liquid chromatograph showed a resolution of 3.74.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a separation and measurement method of besifloxacin hydrochloride and an isomer of besifloxacin hydrochloride. The method is characterized by adopting a chiral chromatographic column which takes cyclodextrin as a filler and adopting a mobile phase system formed by a buffer salt solution and an organic solvent. After the method is adopted, the besifloxacin and the enantiomer of the besifloxacin are effectively separated from each other, and the separation degree of the besifloxacin and the enantiomer of the besifloxacin reaches up to more than 3.5, so that the quality of besifloxacin hydrochloride can be accurately and effectively controlled. Compared with the existing patents and literatures, the method does not need a complicated derivative process and an expensive derivatization reagent on the whole, and is simple in sample pretreatment process, short in analysis time and high in operability. After the method is used, the besifloxacin and the optical isomer of the besifloxacin are simply, rapidly and accurately separated and detected.

Description

technical field [0001] The invention relates to the field of analytical chemistry, in particular to a method for separating and measuring besifloxacin hydrochloride and its optical isomers by liquid chromatography. Background technique [0002] The chemical name of besifloxacin hydrochloride is (R)-7-(3-aminohexahydro-1H-aza -1-base)-8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-carboxylic acid quinoline hydrochloride, its structure is as shown in formula (I) It is a new generation of fluoroquinolones for the treatment of bacterial conjunctivitis, which has shown superior bactericidal effect in clinical practice. The structural formula of besifloxacin hydrochloride is as shown in (I): [0003] [0004] In the structure of besifloxacin hydrochloride, a seven-membered ring side chain with a chiral center is connected to the 7-position, and the configuration of the chiral center is R-type, so there is a configuration of besifloxacin hydrochloride that is S-type The...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): G01N30/02G01N30/06
Inventor 陈超卢凌春饶万兵郭伟康刘国柱陈磊
Owner SUNSHINE LAKE PHARM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap